MENU
+Compare
NVO
Stock ticker: NYSE
AS OF
Jan 17 closing price
Price
$78.69
Change
-$4.38 (-5.27%)
Capitalization
368.92B

NVO Novo-Nordisk A/S Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products

Industry Biotechnology
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NVO with price predictions
Jan 08, 2025

NVO's RSI Indicator climbs out of oversold territory

The RSI Indicator for NVO moved out of oversold territory on January 08, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 14 similar instances when the indicator left oversold territory. In of the 14 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where NVO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVO advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .

NVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 304 cases where NVO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for NVO turned negative on December 19, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (21.008) is normal, around the industry mean (14.746). P/E Ratio (26.883) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (1.284) is also within normal values, averaging (1.853). Dividend Yield (0.018) settles around the average of (0.013) among similar stocks. P/S Ratio (9.407) is also within normal values, averaging (264.084).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NVO is expected to report earnings to fall 85.67% to 87 cents per share on February 05

Novo-Nordisk A/S NVO Stock Earnings Reports
Q4'24
Est.
$0.88
Q3'24
Beat
by $5.24
Q2'24
Beat
by $9.46
Q1'24
Beat
by $4.93
Q4'23
Beat
by $0.05
The last earnings report on November 06 showed earnings per share of $6.12, beating the estimate of 88 cents. With 21.27M shares outstanding, the current market capitalization sits at 368.92B.
A.I.Advisor
published Dividends

NVO paid dividends on August 26, 2024

Novo-Nordisk A/S NVO Stock Dividends
А dividend of $0.52 per share was paid with a record date of August 26, 2024, and an ex-dividend date of August 16, 2024. Read more...
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OZK49.744.40
+9.70%
Bank OZK
RPID1.230.03
+2.50%
Rapid Micro Biosystems
URI771.0013.58
+1.79%
United Rentals
GWRS11.960.10
+0.80%
Global Water Resources
ESTA34.56-0.08
-0.23%
Establishment Labs Holdings

NVO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVO has been closely correlated with NONOF. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVO jumps, then NONOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
-5.27%
NONOF - NVO
70%
Closely correlated
-4.67%
GALT - NVO
34%
Loosely correlated
-0.80%
BCAB - NVO
30%
Poorly correlated
+1.46%
AXON - NVO
29%
Poorly correlated
+1.37%
LABFF - NVO
29%
Poorly correlated
N/A
More

Groups containing NVO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
-5.27%
Pharmaceuticals
category (309 stocks)
38%
Loosely correlated
+0.20%